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Tome-1, a Trigger of Mitotic Entry, Is Degraded
during G1 via the APC
subunits CDC27 and CDC16 is required for achieving
maximal APC activity during mitosis (King et al., 1995;
Kotani et al., 1999; Kramer et al., 2000). One of the
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Harvard Medical School trolled by both proteolytic and phosphorylation mecha-
nisms during the cell cycle (King et al., 1996, 1995). Cdk1200 Longwood Avenue
Boston, Massachusetts 02115 activation occurs when inhibitory phosphorylations
(T14, Y15) are removed from cdk1 by the phosphatase3 National Cancer Institute-Frederick
1050 Boyles Street CDC25. CDC25 phosphatase activity and the opposing
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as a switch (Gautier et al., 1991; Russell and Nurse,
1987; Solomon et al., 1991). When CDC25 activity is
greater than wee1 activity, cdk1 becomes active, andSummary
the cell enters mitosis.
One way cells insure that CDC25 activity is greaterEntry into mitosis requires the activation of cdk1/
cyclin B, while mitotic exit is achieved when the same than wee1 activity at the end of G2 is by degrading wee1
at this time. Recent studies have indicated that wee1 iskinase activity decreases, as cyclin B is degraded.
Cyclin B proteolysis is mediated by the anaphase pro- degraded during G2 in a CDC34-dependent manner in
Xenopus egg extracts (Michael and Newport, 1998).moting complex, or APC, an E3 ligase that is active at
anaphase in mitosis through G1. We have identified a Since CDC34 is an E2 enzyme known to interact with
the SCF ubiquitin ligase components Skp-1, Cul-1, Rbx,G1 substrate of the APC that we have termed Tome-1,
for trigger of mitotic entry. Tome-1 is a cytosolic pro- and the F box substrate receptor protein, wee1 degrada-
tion should require the activity of at least one SCF ligasetein required for proper activation of cdk1/cyclin B and
mitotic entry. Tome-1 associates with Skp-1 and is (Peters, 1998). However, the identity of the F box protein
required for vertebrate wee1 degradation is unknown.required for degradation of the cdk1 inhibitory tyrosine
kinase wee1; Tome-1 therefore appears to be acting Vertebrate wee1 is thought to be part of the DNA
replication checkpoint pathway (Michael and Newport,as part of an SCF-type E3 for wee1. Degradation of
Tome-1 during G1 allows for wee 1 accumulation dur- 1998). The control of wee1 degradation during the so-
matic cell cycle could provide a critical link betweening interphase, thereby providing a critical link be-
tween the APC and SCF pathways in regulation of DNA replication and mitotic entry. Therefore, identifica-
tion of factors essential for wee1 degradation is crucialcdk1/cyclin B activity and thus mitotic entry and exit.
for understanding both mitotic entry and the DNA repli-
cation checkpoint pathway.Introduction
We have identified a factor, Tome-1, required for wee1
degradation and mitotic entry in Xenopus egg extracts.Progression through the eukaryotic cell cycle requires
the coordinated activity of proteolytic triggers and ki- Tome-1 is a protein that contains an F box motif. Inter-
estingly, it is degraded during the G1 phase of the cellnase cascades (King et al., 1996). A key regulatory com-
plex essential for coordinating the cell cycle in mitosis cycle in an APC-dependent manner to allow wee1 to
accumulate during S phase and reset the CDC25/wee1is the anaphase promoting complex or APC. The APC
is an E3 ligase that mediates transfer of ubiquitin to switch.
critical cell cycle regulators such as cyclin B, securin,
and geminin, thereby targeting them for destruction by Results
the 26S proteasome (Peters, 1999).
The timing of APC substrate recognition is precisely Tome-1 Is a Novel Substrate of APCCDH1
regulated during the cell cycle. APC only targets sub- To identify novel substrates of the G1 active APC, we
strates for degradation during mitosis and G1 (Fang et modified an in vitro expression cloning strategy used
al., 1998). For the APC to be active at these phases of previously to clone three novel mitotic substrates of the
the cell cycle, it must associate with one of two WD40 APC: geminin, vertebrate securin, and Xkid (Funabiki
containing proteins, CDC20 or CDH1. CDC20 activates and Murray, 2000; McGarry and Kirschner, 1998; Zou et
the APC during mitosis, while CDH1 binds the APC at al., 1999). After in vitro translating pools of Xenopus
the end of mitosis and throughout G1. CDC20 levels laevis cDNAs in an 35S-labeling reticulocyte lysate trans-
decrease dramatically during G1, since CDC20 itself is a lation system, we incubated the translated products with
substrate of the APC when activated by CDH1 (APCCDH1) Xenopus egg extracts in the presence or absence of
(Fang et al., 1998; Visintin et al., 1997). recombinant CDH1. Since there is little, if any, expres-
APC activity is also positively regulated by phosphory- sion of CDH1 in the egg, we were able to use Xenopus
lation. For example, phosphorylation of the core APC egg extracts as a source of CDH1-deficient APC (Lorca
et al., 1998). After termination of the degradation reac-
tions, SDS-PAGE analysis, and autoradiography, we*Correspondence: marc@hms.harvard.edu
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identified proteins that were degraded specifically in the when there is the greatest proportion of cells in the G2
or M phases of the cell cycle. By contrast, both cyclinpresence of APCCDH1. We then isolated the correspond-
ing cDNAs to these proteins through a selection proce- B and Tome-1 levels decreased as the proportion of
cells in the G1 phase of the cell cycle increased, sug-dure described in Lustig et al. (1997). We named one of
the proteins Tome-1, since we later discovered that it gesting that both proteins are degraded at this time.
A second indication that Tome-1 levels fluctuatefunctions as a trigger of mitotic entry.
Xenopus Tome-1 is 30% identical to human Tome-1, throughout the cell cycle came when we immunostained
CFPAC cells with the anti-Tome-1 antibody. We foundcontains two N-terminal destruction boxes, and a
C-terminal KEN (Figure 1A). The presence of a KEN se- that the intensity of the immunofluorescence signal for
Tome-1 was greater in mitotic cells than in nonmitoticquence in Tome-1 suggested that Tome-1 is a bona
fide substrate of the APC. To test this claim, we asked cells (Figure 2C). We also observed that in almost all
cells, the endogenous Tome-1 was predominantly cyto-whether Tome-1 degradation can be competitively in-
hibited by adding increasing concentrations of a known solic (Figure 2C). Further, when we overexpressed Tome-1
in tissue culture cells, it was exclusively cytosolic. (Fig-APC substrate. As illustrated in Figure 1B, Tome-1 is
degraded in a CDH1-dependent manner, but this degra- ure 2D).
dation is inhibited greatly in the presence of the N-ter-
minal region of cyclin B. To test whether degradation Tome-1 Associates with Skp-1
of Tome-1 is proteasome mediated, we performed deg- The observation that Tome-1 is a cytosolic protein
radation reactions in the presence of 100 M of the whose expression is greatest at mitosis indicated that it
proteasomal inhibitor MG132 (Lee and Goldberg, 1998). may have an essential function at this time. We reasoned
Under these conditions, which are known to inhibit pro- that we could potentially discover the mitotic cellular
teasomal activity, no degradation of Tome-1 was ob- pathway in which Tome-1 functions by identifying Tome-
served, suggesting that active proteasomes are required 1-interacting proteins. We therefore purified Tome-1
for degradation of Tome-1. from nocodazole-arrested XTC cells and assayed asso-
To determine if Tome-1 is strictly an APCCDH1 substrate ciated proteins. When these extracts were fractionated
or both an APCCDH1 and an APCCDC20 substrate, we as- by size exclusion chromatography, we observed that
sayed degradation of Tome-1 in mitotic extracts. We Tome-1 elutes as part of a complex with an apparent
used a nondegradable version of cyclin B (90) to drive molecular weight of 400 kDa. Tome-1 complexes were
interphase extracts into mitosis, thereby activating detected by immunoblot analysis of column fractions
APCCDC20. We then assayed degradation of Tome-1 in using an anti-Tome-1 antibody (Figure 3A). Since a two-
these extracts. As illustrated in Figure 1C, although hybrid screen indicated that Tome-1 may interact with
Tome-1 is phosphorylated as indicated by its reduced the SCF components Skp-1 and Cul-1 (data not shown),
electrophoretic mobility on SDS-PAGE, it is not de- we wondered if these proteins were present in the
graded in mitotic extracts, suggesting that it is only Tome-1 complex. Using anti-Skp-1, anti-Cul-1, and anti-
recognized by APCCDH1 and not by APCCDC20. Tome-1 antibodies, we found that Skp-1 and Cul-1 did
Recognition of substrates by APCCDH1 requires the indeed cofractionate with Tome-1 in the early steps of
presence of a KEN or RXXL motif in most substrates the purification (data not shown). In fact, when we calcu-
studied thus far (Pfleger and Kirschner, 2000; Pfleger et lated the molecular weight of the Tome-1-containing
al., 2001). To determine if the KEN sequence present in complex by combining size exclusion and sucrose den-
Tome-1 is required for its degradation, we mutated each sity gradient profiles (sedimentation coeffiicient of 5S),
of these three residues to alanine and determined if the we found a mass of 140 kDa, which is the predicted
mutated Tome-1 can be degraded in CDH1-supple- mass of a Tome-1, Skp-1, Cul-1 complex.
mented extracts. Figure 1B demonstrates that mutation To determine if Tome-1 interacts with Skp-1 in vitro,
of the KEN sequence to alanine stabilized Tome-1 in CDH1 we performed an in vitro binding assay with purified
supplemented extracts, suggesting that the C-terminal Tome-1 and 35S-labeled Skp-1. A GST-Tome-1 fusion
KEN sequence present in Tome-1 is necessary for rec- protein was expressed in E. coli, immobilized on gluta-
ognition by CDH1. By contrast, mutation of the destruc- thione beads, and subsequently incubated with in vitro
tion boxes had no effect on CDH1-dependent degrada- translated Skp-1. After washing away the unbound
tion in Xenopus egg extracts (data not shown). Skp-1, we found that significant binding of Skp-1 was
observed to beads containing GST-mTome-1 relative
to beads containing only GST (Figure 3B). Since mostTome-1 Is a Cytosolic Protein Degraded during G1
Our degradation assays suggested that Tome-1 is a proteins known to associate with Skp-1 are F box pro-
teins, we wondered if Tome-1 contained an F box. Closesubstrate of APCCDH1 in vitro. To determine if Tome-1 is
also degraded in vivo, we assayed Tome-1 protein levels inspection of Tome-1 sequences indicated that a puta-
tive F box motif exists in all Tome-1 proteins, suggestingthroughout the somatic cell cycle. We arrested HeLa
cells at the G1/S transition with a double thymidine that Tome-1 may be a member of the F box family of
proteins (Figure 1A). To determine if the F box motif isblock, released the cells by washing away the thymidine,
and then determined the cell cycle profile of these cells necessary for Tome-1 to interact with Skp-1, we engi-
neered versions of Tome-1 lacking putative F boxes andby FACS analysis. We also compared the relative
amounts of cyclin B and Tome-1 by Western analysis. tested if they interacted with Skp-1, as judged by the
glutathione coprecipitation assay. As shown in FigureAs depicted in Figures 2A and 2B, similar to cyclin B
levels, Tome-1 levels are highest 6 hr after cells were 3B, when we removed residues 1–113 from mouse
Tome-1, we found that we lost binding to Skp-1. Bywashed free of thymidine. This corresponds to the time
Tome-1 Is Required for Mitotic Entry
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Figure 1. Tome-1 Is a Novel Substrate of
APCCDH1
(A) Clustal alignment of mouse, human, and
Xenopus Tome-1. The sequences of mouse,
human, and Xenopus Tome-1 are presented.
Identical residues are shaded in black, while
similar residues are boxed in white.
(B) Tome-1 degradation in Xenopus egg ex-
tracts is APC CDH1 dependent and requires
active proteasomes and an intact KEN se-
quence. Xenopus Tome-1 was in vitro trans-
lated in a coupled transcription/translation
system in the presence of 35S-methionine and
added to interphase extracts either con-
taining or lacking CDH1. The degradation re-
actions were allowed to proceed for 0, 30, 60,
or 90 min at room temperature, stopped by
adding SDS sample buffer, and analyzed by
SDS-PAGE. Top: autoradiograph showing
degradation of wt Tome-1 in the presence or
absence of CDH1 in Xenopus egg extracts.
Middle: degradation of a mutant of Tome-1
containing a KEN to AAA mutation at residues
372–374. Bottom: degradation of wt Tome-1
in CDH1-supplemented extracts containing
either 100 M MG132 (left) or 100 M
N-cyclin B.
(C) Tome-1 is stable in a 90-extract. Top: in
vitro translated Tome-1 was incubated with
egg extracts driven into mitosis with 90-
cyclin B, and the extent of degradation was
measured at 0, 30, 60, or 90 min. Bottom:
control indicating that securin is degraded in




Figure 2. Tome-1 Is a Cytosolic Protein De-
graded during G1
(A) Endogenous Tome-1 is degraded during
G1. Graphic representation of the percentage
of HeLa cells in the G2/M, S, or G1 phases
of the cell cycle after culturing cells in the
absence of thymidine for the indicated times.
(B) Anti-Tome-1 or Anti-cyclin B immunoblot
of SDS lysates of cells taken at the various
time points in Figure 2A. Asterisk indicates
position of a nonspecific band present after
cyclin B Western.
(C) Tome-1 is a cytosolic protein. Immunoflu-
orescence of CFPAC cells stained with either
anti-Tome-1 antibody (red) or Dapi (blue). Im-
munofluorescence of Tome-1 in a mitotic cell
(top) and an interphase cell (bottom).
(D) Overexpressed myc-tagged Tome-1 is cy-
tosolic. NIH-3T3 fibroblasts were transfected
with myc-tagged Tome-1 and stained with
anti-myc antibodies.
contrast, removing residues 1–90 from mouse Tome-1 N-Tome-1 Inhibits Mitotic Entry
Since the N-terminal region of Tome-1 was essential fordid not affect the Skp-1-Tome-1 interaction, suggesting
that residues in the 90–113 region are necessary for binding to Skp-1, removing it might create a dominant-
negative form of the protein. To test this, we purifiedbinding Skp-1, and likely contain the F box.
We confirmed that this region contains the F box, recombinant N-Tome-1 and injected it into both halves
of dividing Xenopus embryos at the two-cell stage. Aftersince a mutated form of Tome-1 lacking critical F box
residues did not bind Skp-1. As shown in Figure 3C, several cell divisions, we observed that the embryos
injected with N-Tome-1 had a reduced number of cellsmutating two essential F box residues (LP) to alanine
reduced the extent to which Tome-1 interacted with relative to uninjected embryos. These data suggested
that injection ofN-Tome-1 was affecting cell cycle pro-Skp-1. Also, less Cul-1 precipitated with the F box mu-
tant of Tome-1 relative to wt Tome-1 (Figure 3C). gression, perhaps by inhibiting mitotic entry (Figure 4A).
To determine whetherN-Tome-1 affected mitotic en-Although Xenopus Tome-1 does not contain the LP
residues found in mouse and human Tome-1, it does try, we examined the effects of adding N-Tome-1 in
vitro in Xenopus extracts. Unfertilized egg extracts areassociate with Skp-1 and Cul-1 in vitro. We incubated
recombinant Xenopus Tome-1 in extracts isolated from arrested in meiosis by cytostatic factor (CSF) and can
be induced to cycle into interphase and then into mitosisSF9 cells expressing an HA-tagged version of Cul-1 and
untagged Skp-1. Subsequently, we determined the amount upon calcium addition (Murray, 1991). Cell cycle pro-
gression can be easily monitored in these extracts byof Xenopus Tome-1 associated with anti-HA immuno-
precipitates either containing or lacking HA-Cul-1 and observing nuclear formation and nuclear envelope break-
down of added sperm nuclei, the second being a directSkp-1 by Coomassie staining and LC-MS/MS. As de-
picted in Figure 3D, Xenopus Tome-1 efficiently interacts measure of mitotic entry. To assay whether N-Tome-1
affected mitotic entry in Xenopus egg extracts, wewith HA-Cul-1 and Skp1, but not with HA beads alone.
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no effect on the rate of mitotic entry 120 min after release
from CSF arrest, as condensed nuclei were readily ap-
parent. By contrast, incubation of the same Xenopus
extract with 100 nM N-Tome-1 mutant markedly inhib-
ited mitotic entry, as the chromatin remained decon-
densed 120 min after calcium addition (Figure 4B).
Since mitotic entry was inhibited when we added
N-Tome-1 to an extract, we wondered if it somehow
affected cdk1 activation, a critical step in entering mito-
sis. Cyclin bound cdk1 can oscillate between an active
and inactive pool, with an inhibitory phosphorylation
on tyrosine 15. To determine the activity of cdk1, we
performed Western blots using a phosphotyrosine-spe-
cific anti-cdk1 antibody on samples taken 0, 60, or 120
min after release from CSF arrest. As shown in Figure
4C, addition of buffer had no effect on the extent to
which cdk1 was tyrosine phosphorylated. We found that
there was no tyrosine phosphorylation on cdk1 at the 0
min time point as expected, since cdk1 was active and
there was no detectable inhibitory phosphorylation on
tyrosine 15. The amount of tyrosine phosphorylation on
cdk1 at the 60 min time point, however, increased sub-
stantially as the extract cycled into interphase. As the
extract entered mitosis, the amount of tyrosine phos-
phorylation on cdk1 decreased to the point of undetect-
ability (Figure 4C).
In contrast to what we observed above, addition of
N-Tome-1 greatly affected the amount of tyrosine
phosphorylation on cdk1 relative to the buffer control.
As expected, the amount of tyrosine phosphorylation
on cdk1 at the 0 min time point was low and high at
the 60 min point. However, tyrosine phosphorylation on
cdk1 remained high 120 min after release from CSF,
Figure 3. Tome-1 Associates with Skp-1 indicating that N-Tome-1 addition rendered cdk1 inac-
(A) Tome-1 copurifies with Skp-1. XTC cell extracts were first bound tive and, consequently, inhibited mitotic entry.
to an anion-exchange column (Hi-Trap Q) and eluted using a linear
Wee1 is one of the kinases known to mediate tyrosineNaCl gradient. Peak fractions containing both Tome-1 and Skp-1,
phosphorylation of cdk1. We asked, therefore, whetheras judged by anti-Tome-1 or anti-Skp-1 immunoblots, were further
N-Tome-1 inhibition of mitotic entry was due to wee1.analyzed on a Smart System Superose 6 Column. Fractions from
the Superose 6 column were assayed for Tome-1 or Skp-1 immuno- To test this, we immunodepleted wee1 from egg extracts
reactivity as shown. Position of molecular weights markers (660, and assayed mitotic entry in the presence of N-Tome-1.
440, and 220 kDa) are indicated. We found that removing wee1 overrode the inhibition
(B) Tome-1 associates with Skp-1 in vitro. Autoradiograph demon-
of mitotic entry observed in the presence ofN-Tome-1.strating results of glutathione precipitation assay using 35S-labeled-
As shown in Figure 4D, while mitotic entry occurred inSkp-1 and GST-Tome-1 or an equivalent amount of GST (left) or
mock-depleted extracts, wee1-depleted extracts, andvarious mutants of Tome-1 (right).
(C) Myc-Tome-1 interacts with HA-tagged Skp-1 and Flag-Cul-1. wee1-depleted extracts supplemented with N-Tome-1,
Myc-Tome-1, Myc-Tome1Fbox, or Myc-CR16 were cotransfected mitotic entry was blocked in mitotic extracts supple-
with HA-Skp-1 and Flag-Cul-1, and the extent of the respective mented with N-Tome-1.
interactions determined by anti-myc immunoprecipitations. Western
blots to detect myc, HA, or Flag are provided. Single and double
Tome-1 Is Required for Mitotic Entryasterisks indicate the position of IgG heavy and light chains, respec-
tively. and Wee1 Degradation
(D) Xenopus Tome-1 associates with HA-Cul-1 and Skp-1 in vitro. Although N-Tome-1 inhibited mitotic entry in both em-
Recombinant Xenopus Tome-1 was incubated with extracts of SF9 bryos and extracts, it remained formally possible that
cells expressing HA-Cul-1 and Skp-1 and immunoprecipitated with
the truncated form of the protein had some unexpectedanti-HA beads. The identity of the bands labeled Tm1, Skp-1, and
nonspecific effect. To address this issue, we measuredHA-Cul-1 was confirmed by LC-MS/MS. Single and double asterisks
the effect of immunodepleting endogenous Tome-1 fromindicate the position of IgG heavy and light chains, respectively.
extracts. The consequence of depleting Tome-1 on cdk1
activity was measured by a conventional H1 kinase
assay after releasing the extract from CSF arrest withadded wild-type and N versions of Tome-1 to Xenopus
mitotic (CSF) egg extracts released with calcium and Ca2 for 20 min. Figure 5A illustrates that greater than
95% of the endogenous Tome-1 was depleted with Dy-visually examined the chromatin to determine if nuclear
formation or nuclear envelope breakdown had occurred nal-beads containing the anti-Tome-1 antibody, while
IgG control beads removed little or no Tome-1 from thein each case. As shown in Figure 4B, incubation of these
cycling egg extracts with 100 nM wild-type Tome-1 had extracts. Tome-1-depleted extracts supplemented with
Cell
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Figure 4. N-Tome-1 Inhibits Mitotic Entry
(A) N-Tome-1 injection into embryos inhibits mitotic progression. 3 nl of N-Tome-1 (0.5 mg/ml) was injected into both sides of Xenopus
embryos at the two-cell stage (bottom), and the embryos were filmed along with uninjected embryos (top).
(B) N-Tome-1 inhibits mitotic entry in extracts. Tome-1 or N-Tome-1 was included in extracts cycling between interphase and mitosis.
Nuclear morphology of added sperm nuclei was assayed at 60 or 120 min.
(C) N-Tome-1 increases tyrosine phosphorylation on cdk1. Immunoblot analysis of extracts shown in Figure 4B for tyrosine phosphorylation
on cdk1 at 0, 60, or 120 min after Ca2 addition. “Control” lanes correspond to buffer-only control.
(D) N-Tome-1 does not inhibit mitotic entry in wee1-depleted extracts. Left: wee1-depleted extracts (wee1) or mock-depleted extracts
(wee1) were supplemented with N-Tome-1 and the percent of nuclear envelope breakdown (%NEB) calculated after microscopic analysis
of nuclei. Right: nuclear envelope breakdown was quantified in egg extracts where wee1 was depleted (wee1) or not depleted (wee1).
sperm nuclei entered mitosis much later than mock- Michael and Newport (1998) have recently shown that
mitotic entry in Xenopus egg extracts requires degrada-depleted (IgG-depleted) extracts, suggesting that Tome-1
is required for mitotic entry in Xenopus egg extracts (Fig- tion of the cdk1 inhibitory tyrosine kinase wee1. Since
we observed higher levels of phosphotyrosine on cdk1ure 5A).
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(Y15) in the presence of N-Tome-1 and since wee-1 is of wee1 degradation on Tome-1 in somatic cells, we
one of the kinases that phosphorylates cdk1 at this site, engineered an inducible cell line expressing a dominant-
we tested if removal of Tome-1 affected wee1 degrada- negative version of mouse Tome-1 lacking the F box
tion. CSF extracts were incubated with either anti- motif (N-Tome-1). As indicated in Figure 5E, inducing
Tome-1 antibody or control IgG antibody coupled to expression ofN-Tome-1 increased the amount of wee1
protein A-Dynal beads. After incubation for 2 hr at 4C, present in 293 cells arrested with nocodazole by at least
we added sperm nuclei and assayed the extracts for 10-fold. We concluded from this experiment that expres-
their capacity to degrade 35S-labeled in vitro translated sion of this mutant protein affected the wee1 degrada-
wee1 after first releasing the extract from CSF arrest tion rate, rather than wee1 expression, since we assayed
with Ca2 for 20 min. As shown in Figure 5B, the initial wee1 levels in nocodazole-arrested cells at a time when
rate of wee1 degradation is inhibited 4- to 5-fold when wee1 expression is not transcriptionally regulated (Ka-
Tome-1 is immunodepleted from Xenopus egg extracts. wasaki et al., 2001). Therefore, the expression of a domi-
About half the degradation rate is recovered when nant-negative form of Tome-1 in somatic cells inhibits
Tome-1 is added back to the extract, indicating that wee1 degradation.
Tome-1 is required for wee1 degradation. As a control, We also find that removing Tome-1 from somatic cells
we assayed degradation of another SCF substrate, inhibits wee1 degradation. We reduced Tome-1 expres-
-catenin, in the same extract. As depicted in Figure 5C, sion by transfecting 293 cells with small interfering RNA
degradation of -catenin was unaffected when Tome-1 oligomers and subsequently assayed wee1 degradation
was immunodepleted from Xenopus egg extracts, sug- by pulse-chase analysis of endogenous wee1. As shown
gesting that the inability of wee1 to be degraded in in Figure 5F, wee1 degradation occurs in cells trans-
Tome-1-depleted extracts is not due to a general inhibi- fected with an oligomer that does not affect Tome-1
tion of degradation but, rather, a more specific effect expression (Oligo1), but is inhibited in cells transfected
on wee1. with oligomers that affect Tome-1 expresssion (Oligo2
Studies have indicated that that a feedback loop ex- and Oligo3).
ists in which active cdk1 phosphorylates wee1, thereby
leading to wee1 inactivation (Mueller et al., 1995). This Tome-1 Associates with Phospho-Wee1 and Is
mitotic phosphorylation of wee1 is easily observed by Required for Its Ubiquitinylation
SDS-PAGE, since there is a substantial reduction of Since Tome-1 is required for wee1 degradation in both
wee1 mobility (“mitotic shift”) at this time. Therefore, embryonic and somatic cells, we wondered if it was also
wee1 mobility can be used as a measure of whether an required for wee1 ubiquitinylation. To test this, we first
extract is in mitosis or interphase. As shown in Figure
isolated interphase Xenopus egg extracts and incubated
5B, wee1 does not shift appreciably in Tome-1-depleted
them with sperm nuclei. Subsequently, we added in vitro
extracts (some mitotic shifting is observed at the 120
translated wee1, GST-ubiquitin, or a mixture of GST-
min and 150 min time points upon overexposure of the
ubiquitin and methyl-ubiquitin, the latter being an effec-
film). By contrast, addition of Tome-1 back to the Tome-
tive inhibitor of polyubiquitinylation. We then compared
1-depleted extract restores wee1 shifting at 60 min, indi-
the extent of wee1 polyubiquitinylation in the presencecating that this extract entered mitosis. Similarly, the
or absence of excess Tome-1 after SDS-PAGE and auto-mock-depleted extract contained mitotically shifted
radiography. As can be seen in Figure 6A, including 50wee1 1 hr after the experiment was initiated, indicating
nM Tome-1 in the reaction greatly increased the extentthat this extract cycled from interphase into mitosis.
of wee1 ubiquitinylation. This observed ubiquitinylationRecent studies have also indicated that wee1 degra-
was reduced in the presence of methyl-ubiquitin,dation is accelerated in the presence of nuclei and that
thereby demonstrating that we are indeed measuringthe nuclear pool of wee1 is particularly sensitive to pro-
ubiquitinylation of wee1 as opposed to some other mod-teolysis (Michael and Newport, 1998). To test if Tome-
ification.1 is required for the nuclear-dependent degradation of
Our ubiquitinylation studies indicated that Tome-1 iswee1, we checked to see if removing Tome-1 would
required for wee1 ubiquitinylation. One conclusion fromaffect the degradation rate of nuclear wee1. We per-
these studies is that Tome-1 may interact with wee1 informed an experiment similar to the one described in
a phosphospecific manner. To determine this, we testedFigure 5B, but this time we measured the levels of wee1
whether Tome-1 could interact with wee1 or a mutantin the nuclear fraction, after sedimenting nuclei through
of wee1 in which a serine is changed to alanine at posi-a sucrose cushion. We first insured that the nuclei re-
tion 38, a site found to be phosphorylated in Xenopusmained intact throughout the experiment by preincubat-
interphase extracts (Figure 6G; see Experimental Proce-ing the extract with cycloheximide, which inhibits the
dures). We first incubated wee1 or S38A wee1 with in-synthesis of cyclin B and mitotic entry, and subse-
terphase egg extracts supplemented with nuclei and thequently checked nuclear morphology microscopically
proteasome inhibitor MG132. Subsequently, we incu-after Ca2 addition (data not shown). As shown in Figure
bated these extracts with GST-Tome-1 or an unrelated5D, the nuclear pool of wee1 is completely degraded
protein, GST-VCA. We then determined the amount ofwithin 1 hr when Tome-1 is present, but is not substan-
wee1 or S38A wee1 bound to the GST fusion proteinstially degraded when Tome-1 is depleted from the ex-
by performing a glutathione precipitation assay and per-tract.
forming a Western blot for wee1 (lanes 1–3 for wild-typeThe above observations suggested that Tome-1 is
wee1 and lanes 4–6 for S38A wee1). As shown in Figurerequired for the nuclear-dependent degradation of wee1
6C, GST-Tome-1 precipitated wild-type wee1 (25% ofduring an embryonic cell cycle. Studies have also dem-
input wee1 was pulled down with GST-Tome-1 as op-onstrated that wee1 is degraded in the somatic cell cycle
(Watanabe et al., 1995). To examine the dependence posed to 8% precipitated with GST-VCA). By contrast,
Cell
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Figure 5. Tome-1 Is Required for Mitotic Entry and Wee1 Degradation
(A) Immunodepletion of Tome-1 delays entry into mitosis. CSF extracts were depleted with either anti-Tome-1 antibody or anti-IgG control
antibody and released into interphase. Immunoblot for Tome-1 (left) shows amount of Tome-1 remaining in each of the depleted extracts.
Right: H1 kinase assays were performed for samples taken after calcium release (0 time point is 20 min after Ca2 release).
(B) Immunodepletion of Tome-1 inhibits wee1 degradation. CSF extracts were depleted as in Figure 5A and released with calcium for 20 min,
at which time 35S-labeled-wee1 was added. Aliquots were taken after 0, 30, 60, 120, or 150 min of incubation at room temperature, and
analyzed by SDS-PAGE and autoradiography (Left). Right: quantification of the amount of wee1 remaining presented in left panel.
(C) Immunodepletion of Tome-1 does not affect -catenin degradation. Autoradiograph demonstrating the extent of 35S-labeled -catenin
degradation in a Tome-1-depleted or mock-depleted extract, as in Figure 5B.
(D) Degradation of the nuclear pool of wee1 requires Tome-1. Autoradiograph showing extent of 35S-labeled wee1 degradation observed in
a Tome-1-depleted (Tm1 Dep.) or mock-depleted (Mock Dep.) extract after isolating nuclei.
(E) Expression of N-Tome-1 inhibits wee1 degradation in 293 cells. An inducible cell line was generated expressing N-Tome-1. Left:
Immunoblot for endogenous wee1 or APC2. Right: Myc-tag immunoblot for induced (I) or uninduced (UI) expression of N-Tome-1 in 293
cells arrested with nocodazole for 12 hr.
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the S38A mutant showed little interaction with GST- SCF ligases. Both ligases are similar in that they are
multisubunit complexes containing ring finger and cullinTome-1 (2.5% of input wee1 precipitated with GST-
Tome-1 as compared to 8% precipitated with GST-VCA). proteins. They differ completely in their specificity and
the protein composition of the complex. Furthermore,If phosphorylation of serine residue 38 in the N-ter-
minal sequence of wee1 is necessary for interacting with the APC is only active after metaphase and during G1,
while many SCF ligases target substrates for degrada-Tome-1 and Tome-1 is required for degradation of wee1,
one would anticipate that mutating this site would dra- tion during the S or G2 phases of the cell cycle.
A key SCF substrate degraded during the G2 phasematically affect the degradation rate of wee1. To test
this hypothesis, we compared the ability of wild-type of the cell cycle is the wee1 tyrosine kinase. Wee1 levels
decrease as cells enter G2, thereby allowing for cdk1wee1 and S38A-wee1 to be degraded in Xenopus in-
terphase egg extracts supplemented with sperm nuclei. activation at the end of G2 (Michael and Newport, 1998).
While wee1 degradation was not apparent in the earlyAs shown in Figure 6D, the in vitro degradation rate
of the S38A-wee1 mutant is much lower than the rate studies of the cell cycle in nucleus-free cytoplasmic
extracts, recent studies have shown that it is importantobserved for wild-type wee1, indicating that phosphory-
lation at this site is critical for wee1 degradation. Consis- in somatic cells and very likely in embryonic systems
as well. Before M phase, wee1 remains in the nucleus,tent with this finding is the observation that injecting
S38A-wee1 into dividing embryos inhibits mitotic entry possibly protecting the nucleus from cytoplasmically
activated cdk1 (Heald et al., 1993). Since cdk1/cyclin B(Figure 6E). This inhibition of mitotic entry is likely due
to the fact that in vivo S38A-wee1 is turned over more protein levels would have reached a level capable of
activating mitosis, even a slight reduction in the amountslowly than wild-type wee1 or a kinase inactive mutant
of wee1 (Figure 6F). of wee1 would tip the balance in favor of active cdk1
and allow for nuclear envelope breakdown and mitoticThese studies suggested that the state of phosphory-
lation may be regulated physiologically and serves as progression. We have identified the gene product
Tome-1, which favors the active form of cdk1 by tar-an entry gate to mitotic progression. To test this idea,
we measured the phosphorylation levels on serine 38 by geting wee1 for degradation. One of the most interesting
features of this protein is that it is itself degraded, possi-a new mass spectrometry method that yields absolute
quantitation of protein abundance and phosphorylation bly to insure that degradation of wee1 is transient and
only occurs during G2. Perhaps even more interesting(Stemmann et al., 2002). This analysis indicated that
the levels of wee1 phosphorylation depend on nuclei is that Tome-1 degradation is APC mediated, since it
provides further evidence that the activities of ubiqui-concentration. We also found that the extent of wee1
phosphorylation at serine 38 decreases by 60% when tinylation machineries are interdependent during the cell
cycle.the DNA replication checkpoint is induced in the pres-
ence of nuclei and aphidicolin (Figures 6G and 6H). This
was determined after mass spectrometric based quanti- Tome-1 Is a Substrate of the APC during G1
fication of wee1 isolated from interphase egg extracts, One of the striking characteristics of the cell cycle is
egg extracts supplemented with nuclei, or egg extracts that protein degradation acts as a trigger at several
supplemented with nuclei and aphidicolin. This analysis points to allow cell cycle transitions to occur. For exam-
indicated that 48% of endogenous wee1 was phosphor- ple, the APC-mediated degradation of securin is re-
ylated in egg extracts supplemented with nuclei, 24% quired for cells to proceed from metaphase to anaphase
of wee1 was phosphorylated in egg extracts alone, and (Cohen-Fix et al., 1996), while the SCF-dependent deg-
20% of wee1 was phosphorylated in the presence of radation of cyclin-dependent kinase inhibitors is re-
nuclei and aphidicolin (Figures 6G and 6H). There was quired to promote S phase (Peters, 1998). The APC is
no observable phosphorylation of this site in mitotic also required to ubiquitinylate cyclin B in order to elicit
extracts. mitotic exit. The APC then remains active until the end
of G1, where SCF ligase activity begins to increase in
order to help mediate entry into S phase. ProteolysisDiscussion
may also act to interweave different events in cell cycle
progression. For example, the degradation of gemininStudies in yeast, Xenopus, and mammalian cells have
clearly demonstrated that proteolysis and phosphoryla- by APC in mitosis assures that DNA replication can
occur during the next S phase (McGarry and Kirschner,tion must work in an integrated fashion in order for cell
division to occur faithfully or even at all. Central to this 1998).
The SCF activators, the F box proteins, are alsoprocess are the regulated activities of E3 ubiquitin li-
gases and their substrates. Two of the best-studied E3 thought to be unstable proteins. One mode of regulation
for these proteins has been proposed to be auto-ubiqui-ligases active during the cell cycle are the APC and
(F) Tome-1 is required for wee1 degradation in somatic cells. 293 cells were transfected with small interfering RNA targeting endogenous
Tome-1, and the extent of wee1 degradation assayed after pulse-chase analysis using an anti-wee1 antibody. Middle: autoradiograph of
endogenous wee1 immunoprecipitated from the indicated transfected cells 0, 60, or 120 min after pulse with 35S-methionine and cysteine.
Left: Tome-1 and APC2 Western blot analysis of cells transfected with either Oligo1, Oligo2, or Oligo3. Right: quantification of the amount of
wee1 in middle panel. The cell cycle profile of all three transfected cell lines tested by pulse-chase analysis was analyzed by FACS analysis




Figure 6. Tome-1 Interacts with Phosphorylated Wee1 and Mediates Its Ubquitinylation
(A) Tome-1 addition enhances ubiquitinylation of wee1 in Xenopus egg extracts. Left: in vitro translated 35S-labeled wee1 was added to
Xenopus egg extracts in the presence or absence of recombinant Tome-1 (/Tome-1), GST-ubiquitin (GST-Ub), or methyl-ubiquitin (methyl-
Ub).
(B) Quantification of wee1 ubiquitinylation shown (left) (see Experimental Procedures).
(C) Wt, but not a serine mutant of wee1 at position 38, interacts with GST-Tome-1. In vitro translated wt or S38A wee1 were incubated in
nuclei containing Xenopus interphase egg extracts supplemented with GST-Tome-1 (lanes 1–6) or as a control, a GST fusion with the C
terminus of the actin nucleating scaffolding protein N-WASP, GST-VCA (lanes 7 and 8). The amount of wt-wee1 or S38A that interacted with
GST-Tome-1 was determined by wee1 Western analysis performed on glutathione precipitated samples (lanes 1–3 for wild-type wee1 and
lanes 4–6 for S38A wee1). Lanes 9 and 10 indicate 5% of input wee1 or S38A wee1 used in binding assays.
(D) Wt-wee1, but not a S38A mutant of wee1, is degraded in Xenopus egg extracts. Autoradiograph demonstrating extent of degradation of
35S-labeled wild-type or S38A wee1 in Xenopus egg extracts.
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tion. We think wee1 is likely to be the only critically
important substrate during an embryonic cell cycle since
removing wee1 overrides the mitotic entry defect ob-
served when Tome-1 function is disrupted. Tome-1
might function during other phases of the cell cycle by
mediating degradation of different substrates at differ-
ent times. However, during an embryonic cell cycle there
is no indication that Tome-1 has any other role in the
cell cycle, since we see no effect on DNA replication in




Recombinant human CDH1 was purified from SF9 cells (Fang et al.,
1998) and added to interphase egg extracts (Murray, 1991) to a final
concentration of 0.4 nM (1 l of 0.5 mg/ml CDH1 to 20 l interphase
extract). Pools of cDNAs from a Xenopus neurula stage library were
Figure 7. Model of Tome-1 Activity during the Cell Cycle in vitro translated in a Promega coupled translation/transcription
system and individually added to CDH1 supplemented extracts atTome-1 elicits mitotic entry by decreasing wee1 levels, thereby tip-
a ratio of 1:5 (in vitro translated product to egg extract). The sameping the balance to active cdk1.
translation products were added to egg extracts lacking CDH1.
Sample buffer was added to the degradation reactions after 1 hr.
Positive pools containing proteins degraded specifically in the pres-
tinylation (Zhou and Howley, 1998). In addition to this ence of CDH1 were isolated and the cDNA(s) corresponding to these
mode of regulation, we propose a second, APC-depen- proteins identified through a selection procedure described in Lustig
et al. (1997).dent means of targeting F boxes for degradation. We
believe that this maybe a general mechanism of tagging
Antibody ProductionF boxes for degradation since we found that at least
The cDNA encoding Xenopus Tome-1 was subcloned into the pGEX-two other F box proteins are APCCDH1 substrates in vitro
4T-1 expression vector and the resulting construct transformed into(N.G.A., Y. Wan, and M.W.K., unpublished data).
BL-21 cells. The cells were induced with IPTG (0.5 mM) and the
expressed fusion protein purified on Glutathione beads. The protein
was judged to be 90% pure by Coomassie blue staining and wasTome-1 Is Required for Mitotic Entry
sent to Zymed laboratories for immunization of rabbits. The resultingOur model (Figure 7) posits that Tome-1 mediates mi-
serum was then affinity purified using the Pierce Ab Purificationtotic entry by targeting wee1 for degradation. We have
System.
shown that Tome-1 has an F box and associates with A peptide antibody corresponding to residues 251–268 of human
Cul-1 and Skp-1. We have also shown that Tome-1 asso- Tome-1 (Zymed laboratories) was generated and used in Western
analysis in Figures 2B and 5F.ciates with wee1 in a phosphospecific manner and that
phosphorylation at this site is regulated during the cell
Degradation Assayscycle. An alternative view that Tome-1 is a phospho-
Tome-1 degradation in Xenopus egg extracts was performed asspecific inhibitor of wee1 has been eliminated by show-
previously described (Pfleger and Kirschner, 2000). 100 M ofing that Tome-1 has no effect on wee1 activity (see
MG132 or 100 M of the N terminus of cyclin B were added to
Supplemental Figure S1 online at http://www.cell.com/ interphase egg extracts supplemented with 0.4 nM CDH1 to test
cgi/content/full/113/1/101/DC1). However, it is formally their respective effects on Tome-1 degradation. Wee1 degradation
assays were performed as described (Michael and Newport, 1998)possible that Tome-1 has other targets and that it might
with the following modifications. 35S-labeled-IVT-wee1 was addedinhibit wee1 indirectly in addition to its direct interaction.
to a CSF extract (2 l wee1 to 25 l Xenopus CSF egg extract)Conceivably, Tome-1 could target multiple substrates
released from CSF with 0.8 mM CaCl2. Degradation assays werefor degradation, as is the case for-TRCP, which targets
initiated only after visual inspection of the added sperm nuclei indi-
both -catenin and Ik for degradation (Winston et al., cated that interphase nuclei had formed. -catenin degradation
1999a, 1999b). In a similar manner, Tome-1 could target assays were performed as previously described (Salic et al., 2000).
Ubiquitinylation assays were performed identically to degradationother proteins known to inhibit mitotic entry for degrada-
(E) Injection of S38A wee1 into Xenopus embryos inhibits mitotic entry. In vitro transcribed RNAs encoding the wild-type and mutant forms
of wee1 were made with mMessage mMachine (Ambion). The RNA was diluted to 0.5 ng/nl, and 2 ng was injected into two- to four-cell
embryos. The embryos were collected at stage 9–9.5 and fixed in formalin. The embryos shown are representative of 21 WT, 25 S38A, and
15 kinase inactive mutant (KM)-wee1-injected embryos.
(F) S38A wee1 is stable in vivo. Five embryos were also taken for immunoblot analyses. The exogenous, flag-tagged wee1 was detected with
an anti-flag Ab (M2, Sigma). An agarose gel indicates that an equivalent amount of wee1 RNA was injected into each of the embryos.
(G) Extracted ion current trace of endogenous phosphorylated and unphosphorylated wee1 peptides and the respective synthesized internal
standards.
(H) Phosphorylation of serine 38 decreases in response to the replication checkpoint. Heavy indicates 13C-modified valine (underlined) containing
peptide was used as an internal standard. Quantification of phosphorylated and unphosphorylated endogenous wee1 peptides present in




assays with the following exceptions: 30 mg/ml of GST-ubiquitin In Vitro Binding Assays
To assay association of Tome-1 with Skp-1, 5 g of Tome-1 orwas added to interphase extracts in a 1:1 ratio while methyl-ubiquitin
(Boston Biochem) was added to a final concentration of 10 mg/ml. N-Tome-1 was bound to 5 l of Glutathione beads and incubated
in 100 l of 1 mg/ml ovalbumin in XB buffer. 10 l of in vitro trans-The extent of wee1 poly-ubiquitinylation was measured by quantitat-
ing entire lanes after subtracting the signal generated from input lated, 35S-labeled-Skp-1 was added to glutathione beads containing
Tome-1 or GST alone for 1 hr at room temperature. The beads werewee1.
isolated by centrifugation and washed three times in XB (100 l),
followed by one time in XB  0.3M NaCl. After a final wash in XB,
Tissue Culture and Cell Synchronization the beads were isolated and SDS sample buffer was added to them.
The following protocol was used for cell synchrony experiments. SDS-PAGE followed by phoshorimager analysis indicated the extent
HeLa cells were cultured in suspension in DMEM supplemented of binding of Tome-1 to Skp-1.
with 10% fetal calf serum and 100 g/ml of penicillin/streptomycin In vitro-Tome-1-wee1 binding assays: 50 nM GST-Tome-1 was
at 37C. Subsequently, thymidine (2 mM) was added to cells for 18 added to Xenopus egg extracts (200 l) in the presence of 200
hr. The cells were then released from the thymidine arrest for 6 hr, sperm nuclei/l and 10 l of either in vitro translated wt-wee1 or
at which time thymidine was added for an additional 12 hr. The S38A wee1. The amount of wee1 associated with Tome-1 or GST-
cells were then harvested, and the thymidine was washed away to VCA was determined after washing the beads three times with CSF-
generate thymidine released cells. The thymidine released cells were XB, SDS-PAGE, and wee1 Western blot.
then cultured for various times (0, 3.5, 6, 7, 8, 9, or 10 hr), harvested
by centrifugation (500  g, 5 min), and lysed in SDS sample buffer. Identification of Serine 38 Phosphorylation
We utilized the In Vitrogen ecdysone system to form an inducible To identify phosphorylation of endogenous wee1, a protocol de-
form of N-Tome-1. All transfections were performed using a stan- scribed in Murakami et al. (1999) was utilized. The identity of the
dard calcium-phosphate method with 2 g of DNA/ 4 104 cells/ml. phosphorylation site was confirmed by mass spectrometry.
To test if myc-tagged Tome-1 and HA-tagged Skp-1 or Flag-Cul-1
interacted in tissue culture cells, cell lysates were prepared from Mass Spectrometry
transfected 293 cells in 25 mM Hepes (pH 7.7); 5 mM MgCl2; 1 mM Silver-stained wee1 bands were excised from SDS-PAGE gels. After
EDTA; 5 mM NaF; 0.1% Triton X-100; 250 mM sucrose; and 10 g/ addition of the 13C-labeled nonphosphorylated and phosphorylated
ml of chymostatin, leupeptin, and pepstatin (Sigma). Cells were peptides as internal standards, the samples were in-gel reduced,
isolated after centrifugation, and a 1:1 ratio of lysis buffer:cell pellet alkylated, and digested as described previously (Shevchenko et al.,
was used. Cell lysates were made after dounce homogenization and 1996). In order to account for the reduced digestion efficiency of
clarified by centrifugation (14,000  g, 15 min). The clarified lysate trypsin when phosphoserine residues are in the 2 position relative
was then added to 5l of anti-myc beads (Santa Cruz) for 1 hr at 4C. to a lysine or arginine residue (Schlosser et al., 2001). NEGPQKG
The beads were subsequently isolated and successively washed in (pS)PVSSWRTNN (a gift from Cell Signaling Technology) was used
lysis buffer containing 100, 200, and 300 mM NaCl. as internal standard (the underlined valine residue was 6 13C-
labeled). Extracted peptides were analyzed by LC/MS using an LCQ-
DECA ion trap mass spectrometer (Thermo Finnigan, San Jose,
Immunofluorescence CA). Quantitation of wee1 was performed as described previously
NIH-3T3 cells were grown on coverslips in the presence of DMEM (Stemmann et al., 2001).
supplemented with 10% fetal calf serum and 100 g/ml of penicillin/
streptomycin at 37C. The cells were fixed after incubation with 4% Acknowledgments
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